ChEMBL ligand: CHEMBL195008
Aryl hydrocarbon receptor in Human [ChEMBL: CHEMBL3201] [GtoPdb: 2951] [UniProtKB: P35869] There should be some charts here, you may need to enable JavaScript!
indoleamine 2,3-dioxygenase 1/Indoleamine 2,3-dioxygenase 1 in Human [ChEMBL: CHEMBL4685] [GtoPdb: 2829] [UniProtKB: P14902] There should be some charts here, you may need to enable JavaScript!
receptor interacting serine/threonine kinase 1/Receptor-interacting serine/threonine-protein kinase 1 in Human [ChEMBL: CHEMBL5464] [GtoPdb: 2189] [UniProtKB: Q13546] There should be some charts here, you may need to enable JavaScript!
receptor interacting serine/threonine kinase 3/Receptor-interacting serine/threonine-protein kinase 3 in Human [ChEMBL: CHEMBL1795199] [GtoPdb: 2191] [UniProtKB: Q9Y572] There should be some charts here, you may need to enable JavaScript!

DB	Assay description	Assay Type	Standard value	Standard parameter	Original value	Original units	Original parameter	Reference
Aryl hydrocarbon receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3201] [GtoPdb: 2951] [UniProtKB: P35869]
ChEMBL	Agonist activity at AHR in human HepG2-Lucia AhR cells stably transfected with DRE by luciferase reporter assay	B	5	pEC50	>10000	nM	EC50	Bioorg Med Chem Lett (2023) 92: 129383-129383 [PMID:37348572]
indoleamine 2,3-dioxygenase 1/Indoleamine 2,3-dioxygenase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4685] [GtoPdb: 2829] [UniProtKB: P14902]
ChEMBL	Competitive inhibition of 6His-tagged human recombinant IDO expressed in Escherichia coli BL21DE3pLys	B	4.92	pKi	12000	nM	Ki	J Med Chem (2015) 58: 9421-9437 [PMID:25970480]
ChEMBL	Inhibition of recombinant human IDO1 by colorimetric method	B	4.94	pKi	11600	nM	Ki	Medchemcomm (2019) 10: 1740-1754 [PMID:32055299]
GtoPdb	Using a purified recombinant human IDO enzyme for in vitro>/i> assays.	-	4.94	pKi	11600	nM	Ki	Nat Med (2005) 11: 312-9 [PMID:15711557]
ChEMBL	Inhibition of human recombinant IDO assessed as inhibition of indoleamine 2,3-dioxygenase to kynurenine conversion after 60 mins by HPLC analysis	B	4.94	pKi	11400	nM	Ki	Bioorg Med Chem (2013) 21: 1159-1165 [PMID:23337802]
ChEMBL	Inhibition of IDO1 (unknown origin)	B	4.94	pKi	11400	nM	Ki	J Med Chem (2015) 58: 8762-8782 [PMID:26207924]
ChEMBL	Inhibition of IDO1 (unknown origin)	B	4.94	pKi	11400	nM	Ki	Eur J Med Chem (2017) 138: 199-211 [PMID:28667875]
ChEMBL	Inhibition of IDO (unknown origin)	B	4	pIC50	100000	nM	IC50	J Med Chem (2020) 63: 1490-1510 [PMID:31622096]
ChEMBL	Inhibition of human recombinant IDO assessed as inhibition of indoleamine 2,3-dioxygenase to kynurenine conversion after 60 mins by HPLC analysis	B	4.11	pIC50	76900	nM	IC50	Bioorg Med Chem (2013) 21: 1159-1165 [PMID:23337802]
ChEMBL	Inhibition of human recombinant His6-tagged IDO1 expressed in Escherichia coli strain BL21DE3pLys	B	4.11	pIC50	76900	nM	IC50	Eur J Med Chem (2022) 227: 113967-113967 [PMID:34752953]
ChEMBL	Inhibition of IDO1 (unknown origin)	B	4.11	pIC50	76900	nM	IC50	Eur J Med Chem (2021) 211: 113071-113071 [PMID:33341650]
ChEMBL	Inhibition of IDO (unknown origin)	B	4.41	pIC50	39080	nM	IC50	Eur J Med Chem (2024) 265: 116123-116123 [PMID:38199165]
ChEMBL	Inhibition of recombinant human IDO1 expressed in COS1 cells by colorimetric method	B	4.89	pIC50	12850	nM	IC50	Medchemcomm (2019) 10: 1740-1754 [PMID:32055299]
ChEMBL	Inhibition of recombinant human IDO using L-Trp as substrate incubated for 60 mins	B	6.96	pIC50	110	nM	IC50	J Med Chem (2020) 63: 1490-1510 [PMID:31622096]
receptor interacting serine/threonine kinase 1/Receptor-interacting serine/threonine-protein kinase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5464] [GtoPdb: 2189] [UniProtKB: Q13546]
ChEMBL	Inhibition of RIPK1 (unknown origin)	B	5.7	pIC50	1980	nM	IC50	Eur J Med Chem (2024) 265: 116123-116123 [PMID:38199165]
ChEMBL	Inhibition of human RIPK1 incubated for 40 min in presence of ATP by ADP-Glo luminescence kinase assay	B	5.94	pIC50	1139	nM	IC50	Bioorg Med Chem (2022) 59: 116686-116686 [PMID:35228069]
ChEMBL	Inhibition of recombinant GST-tagged RIP1 (unknown origin) after 4 hrs by ADP-Glo kinase assay	B	6.12	pIC50	760	nM	IC50	J Med Chem (2017) 60: 972-986 [PMID:27992216]
GtoPdb	Measuring inhibition of cellular necrosis in TNFα-treated FADD-deficient Jurkat cells.	-	6.31	pIC50	490	nM	IC50	Nat Chem Biol (2008) 4: 313-21 [PMID:18408713]
ChEMBL	Inhibition of human recombinant RIPK1 using MBP as substrate preincubated for 15 mins followed by substrate addition and measured after 120 mins in presence of ATP by ADP-Glo kinase assay	B	6.57	pIC50	268	nM	IC50	Eur J Med Chem (2023) 259: 115635-115635 [PMID:37494773]
ChEMBL	Inhibition of recombinant human GST-fused RIPK1 (1 to 497 residues) expressed in baculovirus infected insect Sf9 cells in presence of 32P-gamma-ATP after 30 mins by autoradiogram-based Western blot method	B	6.74	pIC50	182	nM	IC50	Nat Rev Drug Discov (2017) 16: 424-440 [PMID:28280261]
ChEMBL	Enzyme Immuno Assay: RIPK1 protein was over-expressed in HEK293 cell line, to which lysis buffer (50 mM Tris-Cl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.4 mM phenylmethylsulfonyl fluoride (PMSF)) was added for cell lysis. Centrifugation was performed at 13,000 rpm for 10 minutes to separate the supernatant. RIPK1 monoclonal antibody (610459, BD Bioscience) and A/G agarose beads (sc-2003, Santa Cruz Biotechnology) were added thereto, followed by immuno-precipitation in a 4° C. rotator for 12 hours.The compounds of examples of the invention were diluted at the different concentrations of 10 μM˜0.05 μM (10, 5, 1, 0.5, 0.1, 0.05 uM) and mixed with the immuno-precipitated RIPK1 enzyme, followed by reaction in a 24° C. constant-temperature water bath for 15 minutes. Additional reaction was induced for 30 minutes at 30° C. after 100 μM of ATP and 10 μCi[32P] γ-ATP were added thereto. The reaction mixture was washed with buffer once, to which protein loading buffer was added, followed by heating at 100° C. for 3 minutes. The reaction mixture was then loaded on 8% SDS-PAGE gel. Radioactive image of the phosphorylated RIPK1 was detected with FLA-7000 (GE healthcare).	B	7.02	pIC50	95.5	nM	IC50	US-10501473-B2. Fused heterocyclic ring compounds and method of treating retinal disease using same (2019)
ChEMBL	Inhibition of endogenous RIP1 autophosphorylation in human Jurkat cells	B	6.74	pEC50	182	nM	EC50	Nat Chem Biol (2008) 4: 313-321 [PMID:18408713]
receptor interacting serine/threonine kinase 3/Receptor-interacting serine/threonine-protein kinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795199] [GtoPdb: 2191] [UniProtKB: Q9Y572]
ChEMBL	Inhibition of human recombinant RIPK3 using MBP as substrate preincubated for 15 mins followed by substrate addition and measured after 120 mins in presence of ATP by ADP-Glo kinase assay	B	4.3	pIC50	>50000	nM	IC50	Eur J Med Chem (2023) 259: 115635-115635 [PMID:37494773]

ChEMBL data shown on this page come from version 36:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]